NextGen Jane
Oakland, US · Founded 2014 · Delaware corporation · 1 known investors
NextGen Jane runs a longitudinal molecular study of women's menstruation, using an at-home organic cotton tampon collection kit that members mail in to derive genomic insights from uterine samples. The company aims to improve diagnostics and treatment for gynecological conditions such as endometriosis and other menstrual and reproductive health issues.
Founders & leadership
NextGen Jane was founded in 2014 by Stephen Gire and Ridhi Tariyal.
SG
Stephen GireCo-founder
RT
Ridhi TariyalCo-founder
Investors · 1
Reported raises · per SEC filings
Form D private placements$19.5M disclosed across 4 rounds · 2016–2023
▶$7MraisedOct 2023 · 7 investors · Other Health CareRule 506(b)
▶$7MraisedOct 2023 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Stephen GireExecutive Officer, Director
- Deborah KilpatrickDirector
- Ridhi TariyalExecutive Officer, Director
- Adam SharkawyDirector
- Offering amount
- $7.8M
- Amount sold
- $7M
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedJun 2022 · 2 investors · Other Health CareRule 506(b)
▶$1.5MraisedJun 2022 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- STEPHEN GIREExecutive Officer, Director
- RIDHI TARIYALExecutive Officer, Director
- DEBORAH KILPATRICKDirector
- ADAM SHARKAWYDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.7MraisedApr 2019 · 14 investors · Other Health CareRule 506(b)
▶$8.7MraisedApr 2019 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Adam SharkawyDirector
- Stephen GireExecutive Officer, Director
- Ridhi TariyalExecutive Officer, Director
- Deborah KilpatrickDirector
- Offering amount
- $8.7M
- Amount sold
- $8.7M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$2.2MraisedMar 2016 · 7 investors · Other Health CareRule 506(b)
▶$2.2MraisedMar 2016 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Stephen GireDirector
- Ridhi TariyalExecutive Officer, Director
- Offering amount
- $2.4M
- Amount sold
- $2.2M
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlap
Jane16 shared keywordsJane is cloud-based practice management software for interdisciplinary health clinics, handling online booking, charting, scheduling, invoicing, payment processing, and insurance billing. It serves practitioners such as physiotherapists, massage therapists, counsellors, and midwives, with regional data centers in the USA, Canada, UK, and Australia.
Johnson & Johnson14 shared keywordsJohnson & Johnson develops prescription medicines and medical technology across areas including oncology, immunology, neuroscience, cardiopulmonary, cardiovascular, orthopaedics, surgery, and vision. Its two main businesses, Innovative Medicine and MedTech, focus on treating complex diseases through science-based drugs and less invasive, personalized medical devices.
Biogen Idec12 shared keywordsBiogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.
Jane Technologies10 shared keywords
Nexthealth8 shared keywordsNext Health operates wellness clinics offering IV vitamin therapy, NAD+ drips, peptide therapy, and bioidentical hormone optimization delivered through in-lounge sessions and membership plans. It serves consumers focused on longevity and health optimization, with locations in cities including West Hollywood, Century City, Studio City, New York City, Nashville, and Maui.
Companies competing with NextGen Jane for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $267.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does NextGen Jane do?
- NextGen Jane runs a longitudinal molecular study of women's menstruation, using an at-home organic cotton tampon collection kit that members mail in to derive genomic insights from uterine samples. The company aims to improve diagnostics and treatment for gynecological conditions such as endometriosis and other menstrual and reproductive health issues.
- Who founded NextGen Jane?
- NextGen Jane was founded by Stephen Gire, Ridhi Tariyal in 2014.
- Who are NextGen Jane's investors?
- NextGen Jane's investors include Material Impact.
- How much funding has NextGen Jane raised?
- NextGen Jane has disclosed $19.5M raised across 4 rounds.
- Where is NextGen Jane headquartered?
- NextGen Jane is headquartered in Oakland, US.